European guideline and expert statements on the management of narcolepsy in adults and children
Background and aim Narcolepsy is an uncommon hypothalamic disorder of presumed
autoimmune origin that usually requires lifelong treatment. This paper aims to provide …
autoimmune origin that usually requires lifelong treatment. This paper aims to provide …
Disrupted nighttime sleep and sleep instability in narcolepsy
Study Objectives: This review aimed to summarize current knowledge about disrupted
nighttime sleep (DNS) and sleep instability in narcolepsy, including self-reported and …
nighttime sleep (DNS) and sleep instability in narcolepsy, including self-reported and …
Measurement of narcolepsy symptoms in school-aged children and adolescents: the pediatric narcolepsy severity scale
L Barateau, M Lecendreux, S Chenini, AL Rassu… - Neurology, 2021 - AAN Enterprises
Objective We validated the Narcolepsy Severity Scale (NSS) in adults with narcolepsy type 1
(NT1) to quantify the severity, frequency, and consequences of the 5 key narcolepsy …
(NT1) to quantify the severity, frequency, and consequences of the 5 key narcolepsy …
Increased very low frequency pulsations and decreased cardiorespiratory pulsations suggest altered brain clearance in narcolepsy
Background Narcolepsy is a chronic neurological disease characterized by daytime sleep
attacks, cataplexy, and fragmented sleep. The disease is hypothesized to arise from …
attacks, cataplexy, and fragmented sleep. The disease is hypothesized to arise from …
Implications of oxybate dosing regimen for sleep, sleep architecture, and disrupted nighttime sleep in patients with narcolepsy: a commentary
R Rosenberg, R Braceras, W Macfadden… - Neurology and …, 2023 - Springer
Narcolepsy is associated with disrupted nighttime sleep (DNS). Sodium oxybate (SXB;
Xyrem®), administered twice nightly, is indicated for the treatment of cataplexy and …
Xyrem®), administered twice nightly, is indicated for the treatment of cataplexy and …
Central disorders of hypersomnolence
M Blattner, K Maski - CONTINUUM: Lifelong Learning in …, 2023 - journals.lww.com
Central Disorders of Hypersomnolence : CONTINUUM: Lifelong Learning in Neurology
Account Register Activate Subscription Help Subscribe American Academy of Neurology …
Account Register Activate Subscription Help Subscribe American Academy of Neurology …
Linking clinical complaints and objective measures of disrupted nighttime sleep in narcolepsy type 1
Abstract Study Objectives Despite its high frequency in narcolepsy type 1 (NT1), disrupted
nocturnal sleep (DNS) remains understudied, and its determinants have been poorly …
nocturnal sleep (DNS) remains understudied, and its determinants have been poorly …
Changes in sleep pattern during the COVID-19 lockdown in patients with narcolepsy, idiopathic hypersomnia, and restless legs syndrome
L Barateau, S Chenini, AL Rassu, C Denis, Q Lorber… - Neurology, 2022 - AAN Enterprises
Background and Objectives To explore the first coronavirus disease 2019 (COVID-19)
lockdown effect on sleep symptoms in patients with narcolepsy, idiopathic hypersomnia (IH) …
lockdown effect on sleep symptoms in patients with narcolepsy, idiopathic hypersomnia (IH) …
Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture?
M Zhang, CO Inocente, C Villanueva… - CNS Neuroscience …, 2020 - Wiley Online Library
Objective To compare symptoms and sleep characteristics in patients diagnosed with
narcolepsy‐cataplexy (NC) before and after the age of 18 years. Methods De novo patients …
narcolepsy‐cataplexy (NC) before and after the age of 18 years. Methods De novo patients …
Effect of FT218, a once-nightly sodium oxybate formulation, on disrupted nighttime sleep in patients with narcolepsy: results from the randomized phase III REST-ON …
Background Sodium oxybate has been recognized as a gold standard for the treatment of
disrupted nighttime sleep due to narcolepsy. Its short half-life and immediate-release …
disrupted nighttime sleep due to narcolepsy. Its short half-life and immediate-release …